Fox Run Management L.L.C. acquired a new stake in shares of Masimo Co. (NASDAQ:MASI) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 9,841 shares of the medical equipment provider’s stock, valued at approximately $835,000.
A number of other hedge funds also recently modified their holdings of the stock. Koch Industries Inc. boosted its holdings in Masimo by 5,053.7% in the second quarter. Koch Industries Inc. now owns 443,939 shares of the medical equipment provider’s stock worth $439,000 after acquiring an additional 435,325 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of Masimo by 6.9% during the second quarter. Vanguard Group Inc. now owns 4,935,693 shares of the medical equipment provider’s stock worth $450,036,000 after purchasing an additional 318,060 shares during the period. Victory Capital Management Inc. acquired a new stake in shares of Masimo during the third quarter worth about $26,049,000. American Century Companies Inc. raised its position in Masimo by 127.7% during the third quarter. American Century Companies Inc. now owns 476,963 shares of the medical equipment provider’s stock valued at $41,286,000 after acquiring an additional 267,489 shares in the last quarter. Finally, Old Mutual Global Investors UK Ltd. raised its position in Masimo by 41.9% during the third quarter. Old Mutual Global Investors UK Ltd. now owns 808,488 shares of the medical equipment provider’s stock valued at $69,982,000 after acquiring an additional 238,601 shares in the last quarter. 82.57% of the stock is currently owned by institutional investors.
Shares of Masimo Co. (MASI) traded up $1.41 on Friday, hitting $83.47. The company had a trading volume of 545,881 shares, compared to its average volume of 541,859. The stock has a market capitalization of $4,312.98, a PE ratio of 13.21, a price-to-earnings-growth ratio of 3.17 and a beta of 0.85. Masimo Co. has a 52-week low of $75.06 and a 52-week high of $104.71.
MASI has been the subject of several recent research reports. Zacks Investment Research upgraded Masimo from a “hold” rating to a “buy” rating and set a $98.00 price target for the company in a research report on Thursday, November 2nd. Stifel Nicolaus restated a “buy” rating and issued a $108.00 price objective on shares of Masimo in a research report on Friday, November 3rd. Finally, BidaskClub cut Masimo from a “hold” rating to a “sell” rating in a research report on Thursday, December 7th. One analyst has rated the stock with a sell rating, four have given a hold rating and four have assigned a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $97.17.
In other Masimo news, EVP Yongsam Lee sold 5,900 shares of the business’s stock in a transaction on Friday, December 1st. The stock was sold at an average price of $88.31, for a total transaction of $521,029.00. Following the transaction, the executive vice president now owns 70,800 shares of the company’s stock, valued at $6,252,348. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Sanford Fitch sold 2,000 shares of the company’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $93.07, for a total value of $186,140.00. Following the completion of the transaction, the director now directly owns 68,249 shares in the company, valued at approximately $6,351,934.43. The disclosure for this sale can be found here. Insiders have sold 48,098 shares of company stock worth $4,315,261 in the last three months. 16.60% of the stock is currently owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: “Fox Run Management L.L.C. Purchases Shares of 9,841 Masimo Co. (MASI)” was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at https://ledgergazette.com/2018/02/12/9841-shares-in-masimo-co-masi-purchased-by-fox-run-management-l-l-c.html.
Masimo Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.